EUS-guided radiofrequency ablation for intraductal papillary mucinous neoplasms with worrisome features : long-term outcomes in non-surgical patients
EUS-RFA is feasible, safe, and provides durable local control of BD-IPMNs with WF/HRS in patients unsuitable for surgery or declining resection. These results support EUS-RFA as a promising therapeutic option in carefully selected patients. Larger prospective studies are needed to refine selection criteria and confirm long-term oncologic benefit.
Authors
- Marc Barthet (ORCID: https://orcid.org/0000-0001-6589-7160)
- Mohamed Gasmi (ORCID: https://orcid.org/0000-0001-5872-9142)
- Jean Michel Gonzalez
- Diane Lorenzo
- Julien Barras
Institutions
- Hôpital Nord (FR)
Publication Details
- Journal
- Gastrointestinal Endoscopy
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1016/j.gie.2026.03.025
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00